Head of Strategy & Portfolio, Large Molecules at Solvias
Morrisville, North Carolina, United States -
Full Time


Start Date

Immediate

Expiry Date

12 Jun, 26

Salary

0.0

Posted On

15 Mar, 26

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

No

Skills

Strategic Planning, Trade-off Analysis, Portfolio Economics, Financial Modeling, Market Intelligence, Competitive Intelligence, Executive-Level Communication, Stakeholder Influence, Portfolio Management, Marketing Strategy, Business Development, Consulting

Industry

Pharmaceutical Manufacturing

Description
Position Overview The Head of Strategy & Portfolio – Large Molecules is the segment owner for strategy and portfolio decisions, accountable for defining where to play, how to win, and how to allocate capital across the Large Molecules business. The role drives organic and inorganic growth by translating market, customer, and financial insights into clear portfolio choices and investment priorities, while partnering closely with Marketing, Sales, Finance, Science, and Operations to ensure disciplined execution aligned with Solvias’ growth ambitions. Solvias is a global provider of chemistry, manufacturing, and control (CMC) analytics to the life sciences industry. Our expert team combines decades of experience with regulatory expertise across small molecules, biologics, and cell and gene therapies. Solvias offers end-to-end solutions from raw material testing to drug product release and API development for small molecules. Headquartered near Basel, Switzerland, Solvias operates six global Centers of Excellence, all adhering to the highest ISO, GMP, GLP, and FDA standards
Responsibilities
This role serves as the segment owner for strategy and portfolio decisions within the Large Molecules business, being accountable for defining market approach, competitive strategy, and capital allocation. The position drives growth by converting market, customer, and financial data into clear portfolio choices and investment priorities, ensuring execution aligns with company growth goals.
Loading...